Indaptus Therapeutics, Inc. (INDP)
NASDAQ: INDP · Real-Time Price · USD
1.780
0.00 (0.00%)
At close: Mar 27, 2026, 4:00 PM EDT
1.750
-0.030 (-1.69%)
After-hours: Mar 27, 2026, 7:04 PM EDT

Indaptus Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-20.85-15.02-15.42-14.32-7.71
Depreciation & Amortization
-0000
Stock-Based Compensation
1.362.312.972.961.51
Other Adjustments
1.15--0.43-0.13-
Changes in Accounts Payable
2.850.47-0.68-1.15-4.24
Changes in Other Operating Activities
0.67-0.080.16-0.43-0.85
Operating Cash Flow
-14.82-12.32-13.41-13.08-11.29
Capital Expenditures
-----0
Sale of Property, Plant & Equipment
---0.170.45
Purchases of Investments
---6.86-29.6-
Proceeds from Sale of Investments
--2413-
Investing Cash Flow
--17.14-16.430.45
Long-Term Debt Issued
5.71----
Net Long-Term Debt Issued (Repaid)
5.71----
Issuance of Common Stock
6.45.51--35.36
Net Common Stock Issued (Repurchased)
6.45.51--35.36
Issuance of Preferred Stock
6----
Net Preferred Stock Issued (Repurchased)
6----
Other Financing Activities
-0.57-0.76--12.97
Financing Cash Flow
17.544.75--48.34
Net Cash Flow
2.72-7.583.74-29.5137.49
Free Cash Flow
-14.82-12.32-13.41-13.08-11.29
Free Cash Flow Per Share
-15.34-36.88-44.68-44.32-77.31
Levered Free Cash Flow
-11.62-14.63-15.94-15.9-12.8
Unlevered Free Cash Flow
-16.32-14.97-16.9-16.49-12.82
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q